March 27, 2015 |
Our Free Thinking white paper asks, does behavioural economic theory have a role to play in pharmaceutical market research?
Books espousing behavioural economic theories, such as “Thinking Fast and Slow” authored by Daniel Kahneman, have become essential reading for market researchers looking to improve their understanding of how people think, feel and behave.
This theory can be very useful in consumer research, where we already know the power brands have on influencing purchase decisions. But can behavioural economics theory be applied to the pharmaceutical healthcare industry, where treatment decisions are often made in a highly regulated environment and by educated professionals using sound, rational judgement?
Download and read the complimentary whitepaper at http://bit.ly/1L5YhyM
We are one of the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical industry, we use our expertise and experience to deliver intelligent, tailor-made solutions. We provide strategic recommendations that go beyond research, helping our clients to answer their fundamental business challenges.
This content was provided by Inizio
Latest Content from Inizio
We are delighted to welcome Marianne Jaeger as Associate Director to our London headquarters
The need to understand the patient as a key stakeholder is now recognized by pharma across the globe.
Research Partnership has extended its healthcare research and consulting offering to include storytelling deliverables with the hire of multi-media graphic designer Amanda Brent at the company’s London headquarters. Working with…
The latest league tables for the UK market research industry have just been released and reveal Research Partnership to be the fastest growing healthcare market research specialist for 2014.With turnover…
Using our combined knowledge and years of experience of working in these territories, our experts have produced an essential guide to help address some of the core challenges for conducting market…
This white paper explores the global outlook for new immunotherapy products, referencing key opinion leaders and payers to investigate how these products are faring both clinically and financially. Immuno-oncology therapies that…
Published in Medical Marketing & Media November 2015
Using in-depth-interviews to determine how to maximise the commercial opportunities in different emerging markets
Published in eyeforpharma 16 November by Rachel Howard
Our latest case study demonstrates how a mobile app methodology was used to deliver key insights into issues faced by COPD patients
